IAC Express 2011 |
|
Issue number 911: January 31, 2011 |
|
|
| Please click here to subscribe to IAC Express
as well as other FREE IAC periodicals. |
|
Contents
of this Issue
Select a title to jump to the article. |
- CDC
issues new "General Recommendations on Immunization: Advisory Committee on
Immunization Practices"
- CDC
issues updated recommendations for use of meningococcal conjugate vaccines
- Spotlight
on immunize.org: quick access to ACIP recommendations
- IAC's
Video of the Week explains how the GAVI Alliance's finance mechanisms
raise funds to provide immunization services
- Bill &
Melinda Gates Foundation and the Crown Prince of Abu Dhabi pledge $100
million to purchase and deliver childhood vaccines to Pakistan and
Afghanistan
- Influenza
vaccination is recommended for almost everyone, so please keep
vaccinating!
-
Award-winning DVD! "Immunization Techniques: Best Practices with Infants,
Children, and Adults"--from the California Department of Public Health,
Immunization Branch
- Register
for the 2011 National Immunization Conference by February 18 to get the
early-bird rate
- MMWR
publishes report on a case of diphtheria-like illness in Idaho in 2010
-
Rotavirus vaccine VIS now available in Karen language
- WHO
publishes the December 2010 meeting report of the Global Advisory
Committee on Vaccine Safety
- World
Vaccine Congress scheduled for April 11-14 in Washington, DC
|
| |
| Abbreviations |
|
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
| |
|
Issue 911: January 31, 2011 |
|
|
|
1. |
CDC issues new "General Recommendations on Immunization: Advisory Committee
on Immunization Practices"
On January 28, CDC published "General
Recommendations on
Immunization: Recommendations of the Advisory Committee on
Immunization Practices (ACIP)" as an MMWR Recommendations
and Reports. Portions of the Summary section are reprinted
below.
This report is a revision of the General Recommendations on
Immunization and updates the 2006 statement by the Advisory
Committee on Immunization Practices (ACIP) (CDC. General
recommendations on immunization: recommendations of the
Advisory Committee on Immunization Practices [ACIP]. . . .
Notable revisions to the 2006 recommendations include (1)
revisions to the tables of contraindications and precautions
to vaccination, as well as a separate table of conditions
that are commonly misperceived as contraindications and
precautions; (2) reordering of the report content, with
vaccine risk-benefit screening, managing adverse reactions,
reporting of adverse events, and the vaccine injury
compensation program presented immediately after the
discussion of contraindications and precautions; (3)
stricter criteria for selecting an appropriate storage unit
for vaccines; (4) additional guidance for maintaining the
cold chain in the event of unavoidable temperature
deviations; and (5) updated revisions for vaccination of
patients who have received a hematopoietic cell transplant.
The most recent ACIP recommendations for each specific
vaccine should be consulted for comprehensive details. This
report, ACIP recommendations for each vaccine, and
additional information about vaccinations are available from
CDC at http://www.cdc.gov/vaccines
To access the complete recommendations in ready-to-print
(PDF) format, go to: http://www.cdc.gov/mmwr/pdf/rr/rr6002.pdf
To access the complete recommendations in web-text (HTML)
format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6002a1.htm
Back to top |
| |
|
|
2. |
CDC issues updated recommendations for use of meningococcal conjugate
vaccines
CDC published "Updated Recommendations for Use
of
Meningococcal Conjugate Vaccines--Advisory Committee on
Immunization Practices (ACIP), 2010" in the January 28 issue
of MMWR. Reprinted below are portions of the first paragraph
of the recommendations, as well as the complete text of two
sections: (1) Recommendation for Routine Vaccination of
Persons Aged 11 Through 18 Years and (2) CDC Guidance for
Transition to an Adolescent Booster Dose.
On October 27, 2010, the Advisory Committee on Immunization
Practices (ACIP) approved updated recommendations for the
use of quadrivalent (serogroups A, C, Y, and W-135)
meningococcal conjugate vaccines (Menveo, Novartis; and
Menactra, sanofi pasteur) in adolescents and persons at high
risk for meningococcal disease. These recommendations
supplement the previous ACIP recommendations for
meningococcal vaccination. . . . This report summarizes two
new recommendations approved by ACIP: (1) routine
vaccination of adolescents, preferably at age 11 or 12
years, with a booster dose at age 16 years and (2) a 2-dose
primary series administered 2 months apart for persons aged
2 through 54 years with persistent complement component
deficiency (e.g., C5-C9, properidin, factor H, or factor D)
and functional or anatomic asplenia, and for adolescents
with human immunodeficiency virus (HIV) infection. CDC
guidance for vaccine providers regarding these updated
recommendations also is included. . . .
RECOMMENDATION FOR ROUTINE VACCINATION OF PERSONS AGED 11
THROUGH 18 YEARS
ACIP recommends routine vaccination of persons with
quadrivalent meningococcal conjugate vaccine at age 11 or 12
years, with a booster dose at age 16 years. After a booster
dose of meningococcal conjugate vaccine, antibody titers are
higher than after the first dose and are expected to protect
adolescents through the period of increased risk through age
21 years. For adolescents who receive the first dose at age
13 through 15 years, a one-time booster dose should be
administered, preferably at age 16 through 18 years, before
the peak in increased risk. Persons who receive their first
dose of meningococcal conjugate vaccine at or after age 16
years do not need a booster dose. Routine vaccination of
healthy persons who are not at increased risk for exposure
to N. meningitidis is not recommended after age 21 years. .
. .
CDC GUIDANCE FOR TRANSITION TO AN ADOLESCENT BOOSTER DOSE
Some schools, colleges, and universities have policies
requiring vaccination against meningococcal disease as a
condition of enrollment. For ease of program implementation,
persons aged 21 years or younger should have documentation
of receipt of a dose of meningococcal conjugate vaccine not
more than 5 years before enrollment. If the primary dose was
administered before the 16th birthday, a booster dose should
be administered before enrollment in college. The booster
dose can be administered anytime after the 16th birthday to
ensure that the booster is provided. The minimum interval
between doses of meningococcal conjugate vaccine is 8 weeks.
. . .
IAC Express editor's note: Table 2, titled "Summary of
meningococcal conjugate vaccine recommendations, by risk
group--Advisory Committee on Immunization Practices (ACIP),
2010," is an especially useful resource.
To access the complete recommendations in ready-to-print
(PDF) format, go to: http://www.cdc.gov/mmwr/pdf/wk/mm6003.pdf and see pages 72-76.
To access the complete recommendations in web-text (HTML)
format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a3.htm
Back to top |
| |
|
|
3. |
Spotlight on immunize.org: quick access to ACIP recommendations
Looking for quick access to official
recommendations of
CDC's Advisory Committee on Immunization Practices (ACIP)?
Look no further. IAC's ACIP web section provides up-to-date
access to ACIP vaccine recommendations, which are arranged
by date, vaccine, and topic.
For IAC's main page of ACIP recommendations, which is
organized chronologically by recommendation release dates,
go to: http://www.immunize.org/acip
For IAC's ACIP Vaccine Index section, go to:
http://www.immunize.org/acip/acip_vax.asp
For ACIP statements arranged by special topic, go to:
http://www.immunize.org/acip/acip_topic.asp
For additional information about ACIP, including links to
CDC's ACIP web section, VFC resolutions, and CDC's vaccine
price list, go to: http://www.immunize.org/acip/acip_resources.asp
Back to top |
| |
|
|
4. |
IAC's Video of the Week explains how the GAVI Alliance's finance mechanisms
raise funds to provide immunization services
IAC encourages IAC Express readers to watch a
5-minute video
that explains how the GAVI Alliance pioneered innovative
finance mechanisms to raise funds to buy affordable vaccines
and provide immunizations.
The video will be available on the home page of IAC's
website through February 6. To access it, go to:
http://www.immunize.org and click on the image under the
words Video of the Week. After February 6, access the video
directly on YouTube at http://www.youtube.com/watch?v=KWd-n82e5WY
To learn more about the GAVI Alliance, go to:
http://www.gavialliance.org
Remember to bookmark IAC's home page to view a new video
every Monday. To view an IAC Video of the Week from the
past, go to the video archive at http://www.immunize.org/votw
Back to top |
| |
|
|
5. |
Bill & Melinda Gates Foundation and the Crown Prince of Abu Dhabi pledge $100
million to purchase and deliver childhood vaccines to Pakistan and
Afghanistan
On January 26, Bill Gates, co-chair of the Bill &
Melinda
Gates Foundation, and His Highness Sheikh Mohammed bin Sayed
Al Nahyan, Crown Prince of Abu Dhabi, announced that each
will donate $50 million to purchase and deliver childhood
vaccines to Pakistan and Afghanistan. Two-thirds of the $100
million will go to the GAVI Alliance for purchasing and
delivering pneumococcal vaccine and pentavalent vaccine
(which protects against diphtheria, pertussis, tetanus,
hepatitis B, and Haemophilus influenzae type B [Hib]). One-third will go to the World Health Organization and UNICEF to
purchase polio vaccine.
Additional information is available in a PR Newswire press release
here.
Back to top |
| |
|
|
6. |
Influenza vaccination is recommended for almost everyone, so please keep
vaccinating!
Influenza vaccination is recommended for everyone
age 6
months and older, so please keep vaccinating your patients.
If you don't have influenza vaccine, you can direct patients
to the Google Flu Vaccine Finder. It helps the public find
nearby locations where influenza vaccine is available. It's
as simple as entering a zip code. Visit the Google Flu
Vaccine Finder: http://www.google.com/flushot
To purchase supplies of influenza vaccine, visit IVATS, the
Influenza Vaccine Availability Tracking System. IVATS is
operated by the National Influenza Vaccine Summit and
provides information about vaccine manufacturers and
distributors who have influenza vaccine available for
purchase. To access IVATS, go to:
http://www.preventinfluenza.org/ivats
Following is a list of resources related to influenza
disease and vaccination for healthcare professionals and the
public.
To access IAC's handouts related to influenza, including
screening questionnaires, patient education pieces, and
sample standing orders, go to:
http://www.immunize.org/handouts/influenza-vaccines.asp
Back to top |
| |
|
|
7. |
Award-winning DVD! "Immunization Techniques: Best Practices with Infants,
Children, and Adults"--from the California Department of Public Health,
Immunization Branch
The
California Department of Public Health (CDPH),
Immunization Branch, has updated its award-winning training
video, "Immunization Techniques: Best Practices with
Infants, Children, and Adults." The 25-minute program can be
used to train new employees and to refresh the skills of
experienced staff. The video demonstrates the skills and
techniques needed to administer vaccines to patients of all
ages. It includes instruction on the following:
- Selecting, preparing, and administering injectable, oral,
and nasal vaccines
- Documenting immunizations
- Making patients comfortable and educating them
- Facilitating staff and patient
communication
Prices start at $17 each for 1-9 copies and are greatly
reduced for large orders, dropping to $4.25 each for 1,000-1,500 copies.
To learn more about the DVD, and find out how to order it,
go to: http://www.immunize.org/shop/toolkit_iztechdvd.asp
For quotes on larger quantities, call (651) 647-9009 or
email admininfo@immunize.org
The Immunization Action Coalition is the only nationwide
vendor of this new DVD.
Note for healthcare settings located in California: Contact
your local health department immunization program for a free
copy.
Back to top |
| |
|
|
8. |
Register for the 2011 National Immunization Conference by February 18 to get the
early-bird rate
The 2011 National Immunization Conference (NIC)
will be held
March 28-31 in Washington, DC. Register early and save
money!
Here are the registration rates and cutoff dates:
-
Early-bird registration, through 2/18/2011--$225
-
Regular registration, through 3/11/2011--$250
-
On-site registration--$275
To access more information, including a draft agenda, and to
register, go to: http://www.cdc.gov/vaccines/events/nic
Back to top |
| |
|
|
9. |
MMWR
publishes report on a case of diphtheria-like illness in Idaho in 2010
CDC
published "Notes from the Field: Respiratory Diphtheria-Like Illness Caused by Toxigenic Corynebacterium ulcerans--Idaho, 2010" in the January 28 issue of MMWR. A portion of
the first paragraph and the entire last paragraph are
reprinted below.
On September 12, 2010, the Idaho Department of Health and
Welfare was notified of a case of respiratory diphtheria-like illness in an Idaho man aged 80 years whose pharyngeal
specimens yielded Corynebacterium ulcerans. . . .
Antibiotic treatment of diphtheria-like illness caused by C.
ulcerans should follow clinical guidelines for patients
infected with C. diphtheriae. Unlike C. diphtheriae
infections, human-to-human transmission of C. ulcerans
infections has not been documented; therefore, postexposure
antibiotic prophylaxis was not administered to close
contacts of the Idaho patient. However, because studies on
the transmission of C. ulcerans are limited, vaccination
status of contacts should be assessed and brought up-to-date, if necessary, with an age-appropriate diphtheria-toxoid-containing vaccine, which prevents disease from
toxigenic strains of C. diphtheriae and C. ulcerans. CDC
recommends that adults receive a diphtheria-toxoid-containing vaccine every 10 years after completing a primary
childhood vaccination series.
To access the complete article in web-text (HTML) format, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a4.htm
Back to top |
| |
|
|
10. |
Rotavirus vaccine VIS now available in Karen language
The VIS for rotavirus vaccine is now available in
Karen
(spoken in Burma and Thailand). IAC gratefully acknowledges
the Minnesota Department of Health for the translation.
To access the Karen translation of the VIS for rotavirus
vaccine, as well as the rotavirus vaccine VIS in English and
other translations, go to:
http://www.immunize.org/vis/vis_rotavirus.asp
For information about the use of VISs, and for VISs in more
than 35 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
Back to top |
| |
|
|
11. |
WHO publishes the December 2010 meeting report of the Global Advisory
Committee on Vaccine Safety
On January 28, the WHO publication Weekly
Epidemiological
Record (WER) published an article titled "Global Advisory
Committee on Vaccine Safety, December 2010." An expert
clinical and scientific advisory body, the committee deals
independently and with scientific rigor with vaccine safety
issues of potential global importance.
At the December meeting, the committee reviewed or examined
the following: (1) new data related to the risk of
intussusception after rotavirus vaccination; (2) new data on
the safety of pandemic influenza A (H1N1) 2009 vaccines;
(3) the experience of using yellow fever vaccines among HIV-positive people; and (4) the experiences of three West
African countries in monitoring the safety of a new
meningitis A conjugate vaccine.
To access a ready-to-print (PDF) version of the January 28
WER issue, go to: http://www.who.int/wer/2011/wer8605.pdf
Back to top |
| |
|
|
12. |
World Vaccine Congress scheduled for April 11-14 in Washington, DC
The World Vaccine Congress will be held in
Washington, DC,
on April 11-14.
For comprehensive information, including the conference
brochure and access to online registration, go to:
http://www.terrapinn.com/conference/world-vaccine-congress-washington
Back to top |
| |
|
|
